These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36822454)

  • 1. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency in Zhejiang province, China.
    Cheng Y; Chen P; Yu Z; Yin X; Zhang C; Miao H; Huang X
    Clin Chim Acta; 2023 Mar; 542():117266. PubMed ID: 36822454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Follow up and gene mutation analysis in cases suspected as 3-methylcrotonyl-coenzyme A carboxylase deficiency by neonatal screening].
    Ye J; Gong L; Han L; Qiu W; Zhang H; Gao X; Jin J; Xu H; Gu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):409-14. PubMed ID: 25190158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Methylcrotonyl-CoA carboxylase deficiency newborn screening in a population of 536,008: is routine screening necessary?
    Wang H; Liu S; Wang B; Yang Y; Yu B; Wang L; Wang T
    J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1321-1326. PubMed ID: 31730530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment.
    Stadler SC; Polanetz R; Maier EM; Heidenreich SC; Niederer B; Mayerhofer PU; Lagler F; Koch HG; Santer R; Fletcher JM; Ranieri E; Das AM; Spiekerkötter U; Schwab KO; Pötzsch S; Marquardt I; Hennermann JB; Knerr I; Mercimek-Mahmutoglu S; Kohlschmidt N; Liebl B; Fingerhut R; Olgemöller B; Muntau AC; Roscher AA; Röschinger W
    Hum Mutat; 2006 Aug; 27(8):748-59. PubMed ID: 16835865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of eight novel mutations and transcript analysis of two splicing mutations in Chinese newborns with MCC deficiency.
    Yang L; Yang J; Zhang T; Weng C; Hong F; Tong F; Yang R; Yin X; Yu P; Huang X; Qi M
    Clin Genet; 2015 Nov; 88(5):484-8. PubMed ID: 25382614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single mutation in MCCC1 or MCCC2 as a potential cause of positive screening for 3-methylcrotonyl-CoA carboxylase deficiency.
    Morscher RJ; Grünert SC; Bürer C; Burda P; Suormala T; Fowler B; Baumgartner MR
    Mol Genet Metab; 2012 Apr; 105(4):602-6. PubMed ID: 22264772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals.
    Grünert SC; Stucki M; Morscher RJ; Suormala T; Bürer C; Burda P; Christensen E; Ficicioglu C; Herwig J; Kölker S; Möslinger D; Pasquini E; Santer R; Schwab KO; Wilcken B; Fowler B; Yue WW; Baumgartner MR
    Orphanet J Rare Dis; 2012 May; 7():31. PubMed ID: 22642865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary and maternal 3-methylcrotonyl-CoA carboxylase deficiency: insights from the Israel newborn screening program.
    Rips J; Almashanu S; Mandel H; Josephsberg S; Lerman-Sagie T; Zerem A; Podeh B; Anikster Y; Shaag A; Luder A; Staretz Chacham O; Spiegel R
    J Inherit Metab Dis; 2016 Mar; 39(2):211-7. PubMed ID: 26566957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and molecular characterization of 3-Methylcrotonylglycinuria in an Italian asymptomatic girl.
    Cozzolino C; Villani GR; Frisso G; Scolamiero E; Albano L; Gallo G; Romanelli R; Ruoppolo M
    Genet Mol Biol; 2018 Apr./Jun; 41(2):379-385. PubMed ID: 29767664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Methylcrotonyl-CoA carboxylase deficiency: Mutational spectrum derived from comprehensive newborn screening.
    Fonseca H; Azevedo L; Serrano C; Sousa C; Marcão A; Vilarinho L
    Gene; 2016 Dec; 594(2):203-210. PubMed ID: 27601257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded Newborn Screening for Inborn Errors of Metabolism by Tandem Mass Spectrometry in Suzhou, China: Disease Spectrum, Prevalence, Genetic Characteristics in a Chinese Population.
    Wang T; Ma J; Zhang Q; Gao A; Wang Q; Li H; Xiang J; Wang B
    Front Genet; 2019; 10():1052. PubMed ID: 31737040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of cases of 3-methylcrotonyl CoA carboxylase deficiency (3-MCCD) in the California newborn screening program reported in the state database.
    Lam C; Carter JM; Cederbaum SD; Neidich J; Gallant NM; Lorey F; Feuchtbaum L; Wong DA
    Mol Genet Metab; 2013 Dec; 110(4):477-83. PubMed ID: 24103308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and mutational features of maternal 3-methylcrotonyl coenzyme deficiency].
    Gong LF; Ye J; Han LS; Qiu WJ; Zhang HW; Gao XL; Jin J; Xu H; Gu XF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):574-8. PubMed ID: 24078573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical, molecular, and clinical features of patients with glutaric acidemia type 1 identified through large-scale newborn screening in Zhejiang Province, China.
    Lin Y; Zhu X; Zhang C; Yin X; Miao H; Hu Z; Yang J; Wu B; Huang X
    Clin Chim Acta; 2022 May; 530():113-118. PubMed ID: 35367405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A novel compound heterozygous mutation causing 3-methylcrotonyl-CoA carboxylase deficiency].
    Xie B; Luo J; Lei Y; Chen R; Wang J; Zhang S; Fan X; Li W; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):657-61. PubMed ID: 27577216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is L-Carnitine Supplementation Beneficial in 3-Methylcrotonyl-CoA Carboxylase Deficiency?
    Thomsen JA; Lund AM; Olesen JH; Mohr M; Rasmussen J
    JIMD Rep; 2015; 21():79-88. PubMed ID: 25732994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic analysis of newborns with abnormal metabolism of 3-hydroxyisovalerylcarnitine].
    Wu D; Lu B; Yang J; Yang R; Huang X; Tong F; Zheng J; Zhao Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 48(4):390-396. PubMed ID: 31901042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screening.
    Koeberl DD; Millington DS; Smith WE; Weavil SD; Muenzer J; McCandless SE; Kishnani PS; McDonald MT; Chaing S; Boney A; Moore E; Frazier DM
    J Inherit Metab Dis; 2003; 26(1):25-35. PubMed ID: 12872837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.
    Shibata N; Hasegawa Y; Yamada K; Kobayashi H; Purevsuren J; Yang Y; Dung VC; Khanh NN; Verma IC; Bijarnia-Mahay S; Lee DH; Niu DM; Hoffmann GF; Shigematsu Y; Fukao T; Fukuda S; Taketani T; Yamaguchi S
    Mol Genet Metab Rep; 2018 Sep; 16():5-10. PubMed ID: 29946514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An asymptomatic mother diagnosed with 3-methylcrotonyl-CoA carboxylase deficiency after newborn screening.
    Kör D; Mungan NÖ; Yılmaz BŞ; Öktem M
    J Pediatr Endocrinol Metab; 2015 May; 28(5-6):669-71. PubMed ID: 25381946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.